A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia

NCT02260635 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Stopped Study termination due to insufficient efficacy.

Conditions

Hypercholesterolemia

Interventions

DRUG: Evacetrapib
DRUG: Placebo

Sponsor

Eli Lilly and Company